Moxalid (Meloxicam)

Meloxicam, the active ingredient in Moxalid, is a nonsteroidal anti-inflammatory drug presented as an intramuscular injection for intramuscular use. It is employed to relieve pain and diminish inflammation associated with osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders.

GNH USA supplies Moxalid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance for global healthcare providers. The product rigorously complies with European Union pharmaceutical standards and is distributed under a prescription‑only framework.

Meloxicam is an NSAID that reduces inflammation and pain in musculoskeletal disorders.

Osteoarthritis: reduces joint pain, swelling, and stiffness, thereby improving functional mobility and quality of life in affected patients. Rheumatoid arthritis: alleviates inflammatory joint pain and limits progressive stiffness, helping to preserve joint function during active disease phases. Acute musculoskeletal pain: provides rapid analgesic effect for postoperative or injury‑related discomfort, facilitating early mobilization and rehabilitation. Pain relief: offers effective short‑term analgesia for severe pain episodes when other oral agents are unsuitable or insufficient.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection site reactions: erythema, swelling, or pain.

Serious or Rare Side Effects: - Severe gastrointestinal ulceration or bleeding. - Cardiovascular events: myocardial infarction or stroke. - Hepatic dysfunction: elevated transaminases or hepatitis. - Renal impairment: acute kidney injury or worsening chronic kidney disease.

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risk. - Assess renal function: evaluate baseline creatinine and monitor during therapy. - Evaluate cardiovascular risk: avoid use in patients with recent myocardial infarction or uncontrolled hypertension. - Monitor gastrointestinal health: use gastro‑protective agents in patients with history of ulcer disease. - Check hepatic status: avoid in severe liver impairment and monitor liver enzymes periodically. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at ambient temperature: keep in original container, protect from moisture and light.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal function.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced antihypertensive effect and renal impairment. - Lithium: increased lithium levels, risk of toxicity. - Methotrexate: decreased clearance leading to toxicity.